Catharine Scott-Moncrieff, DVM, PhD, explains when she prescribes insulin versus SGLT2 inhibitors, how to monitor for ketosis, and which factors most influence diabetic remission in cats.

Prepare for cold and flu season with type 2 diabetes by getting vaccinated, stocking a sick day kit, planning for extra blood sugar checks, and more.

Semaglutide, a GLP-1 receptor agonist (RA), was associated with a significantly lower risk for adult-onset epilepsy in patients with diabetes than other glucose-lowering drugs (GLDs). Notably, this ...

The relative risk was greatest in younger adults: people under 50 with diabetes had about seven times the risk of sudden ...

While type 1 and type 2 diabetes typically occupy distinct places in healthcare, research is showing an increase of patients ...

Wellgistics Health Inc ( ($WGRX) ) has issued an update. On December 8, 2025, Wellgistics Health, Inc. announced the commercial launch of its ...

The coexistence of type 2 diabetes and obesity represents a major global health challenge that significantly increases cardiovascular and metabolic risk.

Launch targets $16 billion SGLT-2 inhibitor market that serves 33 million type II diabetics in the US, many of whom are ...

A new study finds a possible association between GLP-1 drugs like semaglutide and chronic cough, though the authors are ...

This data is from SOTA-P-CARDIA, a prospective, randomized, double-blind, placebo-controlled trial that exclusively enrolled patients with heart failure with preserved ejection fraction (HFpEF) and ...

The researchers discovered that people who took GLP-1 RAs had a higher chance of developing a chronic cough than those who ...

People with either type 1 or type 2 diabetes have a dramatically higher risk of sudden cardiac death, Danish researchers ...